إعلان
إعلان

NXTC

NXTC logo

NextCure, Inc. Common Stock

13.38
USD
برعاية
-0.21
-1.51%
٠٩ يناير, ١٥:٥٦ UTC -5
مغلق
exchange

بعد الإغلاق

13.37

-0.02
-0.11%

تقارير أرباح NXTC

النسبة الإيجابية المفاجئة

NXTC تفوق 12 من 27 آخر التقديرات.

44%

التقرير التالي

بيانات التقرير القادم
٠٤ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$2.46
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
-23.60%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-50.00%

NextCure, Inc. Common Stock earnings per share and revenue

On ٠٥ نوفمبر ٢٠٢٥, NXTC reported earnings of -3.22 USD per share (EPS) for Q3 25, beating the estimate of -4.06 USD, resulting in a 20.75% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.97% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of -2.46 USD, with revenue projected to reach -- USD, implying an نقصان of -23.60% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, NextCure, Inc. Common Stock reported EPS of -$3.22, beating estimates by 20.75%, and revenue of $0.00, 0% as expectations.
The stock price moved up 1.97%, changed from $9.63 before the earnings release to $9.82 the day after.
The next earning report is scheduled for ٠٤ مارس ٢٠٢٦.
Based on 5 المحللين, NextCure, Inc. Common Stock is expected to report EPS of -$2.46 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان